Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Commerzbank AG stock logo
CRZBY
Commerzbank
$14.89
+0.4%
$13.08
$9.72
$14.89
$18.47B1.1320,378 shs6,874 shs
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
$6.73
$6.81
$4.99
$7.39
N/A0.433 shsN/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
$3.60
+13.6%
$3.48
$2.54
$4.38
$3.21B0.1826 shs1,672 shs
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
$7.29
+3.4%
$7.39
$4.40
$8.13
$11.07B0.611,088 shs13,530 shs
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$107.40
+5.2%
$91.51
$86.00
$120.00
N/A0.275 shs1 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Commerzbank AG stock logo
CRZBY
Commerzbank
+0.42%+6.51%+8.92%+29.93%+31.37%
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
0.00%+3.30%-4.54%+10.25%-20.13%
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
+13.56%+11.46%0.00%+19.13%-17.24%
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
+3.34%+8.16%-7.23%+2.24%+58.82%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
0.00%+15.39%+10.67%+3.55%-8.87%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Commerzbank AG stock logo
CRZBY
Commerzbank
N/AN/AN/AN/AN/AN/AN/AN/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
N/AN/AN/AN/AN/AN/AN/AN/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/AN/AN/AN/AN/AN/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
N/AN/AN/AN/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Commerzbank AG stock logo
CRZBY
Commerzbank
1.50
ReduceN/AN/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
N/AN/AN/AN/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/AN/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
N/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Commerzbank AG stock logo
CRZBY
Commerzbank
$22.00B0.84$6.45 per share2.31N/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
$5.20BN/A$0.63 per share10.62$3.57 per shareN/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/AN/AN/AN/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
$6.41B1.78$0.49 per share14.99$7.90 per share0.92
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$1.43BN/A$9.56 per share11.23$29.27 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Commerzbank AG stock logo
CRZBY
Commerzbank
$2.41B$1.768.466.18N/A10.17%6.30%0.40%N/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
$38.39M$0.1351.73N/A1.38%7.17%3.51%N/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/AN/A0.0025.71N/AN/AN/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
$472.67M$0.4815.19N/A8.21%5.62%0.33%N/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$253.82MN/A0.0026.20N/AN/AN/AN/AN/A

Latest CRZBY, DSRLF, DSEEY, CYAGF, and CYGIY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/19/2024Q4 2023
Commerzbank AG stock logo
CRZBY
Commerzbank
N/A$0.34+$0.34$0.34N/A$2.29 billion
1/31/2024Q1 2024
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
N/A$0.04+$0.04$0.09N/A$1.31 billion
1/31/2024Q3 2024
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
N/A$0.12+$0.12$0.11N/A$2.27 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Commerzbank AG stock logo
CRZBY
Commerzbank
$0.251.68%N/A14.20%N/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
N/AN/AN/AN/AN/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
$0.061.67%N/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
$0.172.33%N/A35.42%N/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/A

Latest CRZBY, DSRLF, DSEEY, CYAGF, and CYGIY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/4/2024
Commerzbank AG stock logo
CRZBY
Commerzbank
$0.25755/2/20245/3/20245/16/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Commerzbank AG stock logo
CRZBY
Commerzbank
N/A
1.07
N/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
0.45
2.63
2.57
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/AN/AN/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
N/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Commerzbank AG stock logo
CRZBY
Commerzbank
N/A
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
N/A
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
N/A
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
N/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Commerzbank AG stock logo
CRZBY
Commerzbank
42,3781.24 billionN/ANot Optionable
CyberAgent, Inc. stock logo
CYAGF
CyberAgent
5,593N/AN/ANot Optionable
CyberAgent, Inc. stock logo
CYGIY
CyberAgent
7,2511.01 billionN/ANot Optionable
Daiwa Securities Group Inc. stock logo
DSEEY
Daiwa Securities Group
14,7311.57 billionN/ANot Optionable
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
3,386N/AN/ANot Optionable

CRZBY, DSRLF, DSEEY, CYAGF, and CYGIY Headlines

SourceHeadline
DiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest UpdateDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Update
americanbankingnews.com - April 15 at 1:42 AM
With Launch of Liaison Plex Platform, DiaSorin Will Offer Flexible Test Pricing PlanWith Launch of Liaison Plex Platform, DiaSorin Will Offer Flexible Test Pricing Plan
360dx.com - April 12 at 3:57 PM
DiaSorin Submits Lyme Disease Test for FDA ApprovalDiaSorin Submits Lyme Disease Test for FDA Approval
360dx.com - January 27 at 9:07 AM
DiaSorin Aims to Deliver Slate of Updated Instruments, New Assays in 2024, 2025DiaSorin Aims to Deliver Slate of Updated Instruments, New Assays in 2024, 2025
360dx.com - December 18 at 1:51 PM
Diasorin SpA DIADiasorin SpA DIA
morningstar.com - December 8 at 12:50 AM
DiaSorin Q3 Non-COVID-19 Revenues Rise 2 Percent, Collaborates With Gilead Sciences on HDV AssayDiaSorin Q3 Non-COVID-19 Revenues Rise 2 Percent, Collaborates With Gilead Sciences on HDV Assay
360dx.com - November 6 at 3:02 PM
DiaSorin Q3 Non-COVID-19 Revenues Rise 2 PercentDiaSorin Q3 Non-COVID-19 Revenues Rise 2 Percent
360dx.com - November 3 at 6:16 PM
Decline in DiaSorins Q2 MDx Revenues Offset by Strength in ImmunodiagnosticsDecline in DiaSorin's Q2 MDx Revenues Offset by Strength in Immunodiagnostics
360dx.com - July 27 at 6:51 PM
DiaSorin S.p.A. reports 1H resultsDiaSorin S.p.A. reports 1H results
msn.com - July 27 at 6:51 PM
DiaSorin Nabs CE Marking for Legionella ImmunoassayDiaSorin Nabs CE Marking for Legionella Immunoassay
360dx.com - July 17 at 9:37 AM
DiaSorin Q1 Revenues Fall 19 Percent on COVID Sales DeclineDiaSorin Q1 Revenues Fall 19 Percent on COVID Sales Decline
360dx.com - May 10 at 5:14 PM
DiaSorin confirms 2023 guidance after Q1 resultsDiaSorin confirms 2023 guidance after Q1 results
msn.com - May 9 at 8:35 AM
DiaSorin warns of lower revenue as COVID-related demand fadesDiaSorin warns of lower revenue as COVID-related demand fades
health.economictimes.indiatimes.com - April 10 at 3:43 PM
DiaSorin S.p.A.DiaSorin S.p.A.
barrons.com - April 6 at 9:14 PM
DiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call TranscriptDiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 29 at 7:49 PM
DiaSorin 2022 Revenues Grow 10 PercentDiaSorin 2022 Revenues Grow 10 Percent
360dx.com - March 27 at 3:37 PM
DiaSorin: Overvalued Italian Healthcare CompanyDiaSorin: Overvalued Italian Healthcare Company
seekingalpha.com - March 4 at 9:42 PM
Cytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinCytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
wsj.com - February 15 at 10:43 PM
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinCytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
finance.yahoo.com - February 13 at 5:31 PM
DiaSorin, PerkinElmer, Roche, Others Nab FDA 510(k) Clearances in NovemberDiaSorin, PerkinElmer, Roche, Others Nab FDA 510(k) Clearances in November
360dx.com - December 7 at 4:31 PM
DIAS.MI - DiaSorin SpA | Stock Price & Latest News | ReutersDIAS.MI - DiaSorin SpA | Stock Price & Latest News | Reuters
reuters.com - October 31 at 2:06 PM
DiaSorin dips over 9%, brokers cite cut to underlying sales growth outlookDiaSorin dips over 9%, brokers cite cut to underlying sales growth outlook
uk.style.yahoo.com - October 27 at 7:11 PM
Becton Dickinson, DiaSorin, Roche Obtain FDA 510(k) Clearances in SeptemberBecton Dickinson, DiaSorin, Roche Obtain FDA 510(k) Clearances in September
360dx.com - October 13 at 4:54 PM
DiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call TranscriptDiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 6:00 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Commerzbank logo

Commerzbank

OTCMKTS:CRZBY
Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, Asia, and internationally. It operates through two segments, Private and Small-Business Customers, and Corporate Clients. The company offers saving, checking, business, and current accounts; term deposits; pension; credit and debit cards; payment solutions; overdraft services; various loans; and insurance products. It also provides trade securities; treasury management; corporate financing; real estate financing; financing advisory; merger and acquisition; foreign trade; trade financing; asset and risk management; and online banking, as well as wealth management services. Commerzbank AG was founded in 1870 and is headquartered in Frankfurt am Main, Germany.
CyberAgent logo

CyberAgent

OTCMKTS:CYAGF
CyberAgent, Inc. engages in the media, internet advertising, game, and investment development businesses primarily in Japan. The company operates Ameba, a blog service; Tapple for online dating; AWA, a music streaming service; and WinTicket for online betting. It also offers internet advertising agency and ad technology services; and smartphone games. In addition, the company operates a programming school for kids and provides application and reward points exchange platform services; artificial intelligence services; and digital transformation services. CyberAgent, Inc. was incorporated in 1998 and is headquartered in Tokyo, Japan.
CyberAgent logo

CyberAgent

OTCMKTS:CYGIY
CyberAgent, Inc. engages in the media, internet advertising, game, and investment development businesses primarily in Japan. The company operates Ameba, a blog service; Tapple for online dating; AWA, a music streaming service; and WinTicket for online betting. It also offers internet advertising agency and ad technology services; and smartphone games. In addition, the company operates a programming school for kids and provides application and reward points exchange platform services; artificial intelligence services; and digital transformation services. CyberAgent, Inc. was incorporated in 1998 and is headquartered in Tokyo, Japan.
Daiwa Securities Group logo

Daiwa Securities Group

OTCMKTS:DSEEY
Daiwa Securities Group Inc., together with its subsidiaries, primarily operates as a securities broker-dealer in Japan and internationally. The company operates through four segments: Retail, Wholesale, Asset Management, and Investment. The Retail segment offers products and services related to asset management, including equities, bonds, investment trusts, wrap account services, insurance, banking services, inheritance-related services, etc. for individual investors and unlisted companies. The Wholesale segment offers sales and trading services of equities and bonds, as well as of foreign exchange and derivative products primarily for institutional investors and corporations; and investment banking services, such as underwriting of securities, M&A advisory, etc. The Asset Management segment structures and manages investment trusts primarily for individual investors and financial institutions; provides investment advisory services; and manages assets. The Investment segment invests in monetary claims, loans, private equities, and real estate properties, as well as energy, infrastructure, and resource sectors. The company also offers research and consulting, and information services, as well as engages in the office work activities. In addition, it is involved in the securities-related, investment advisory and agency, and investment management businesses, as well as lending and borrowing of real estate properties. The company was formerly known as Daiwa Securities Co. Ltd. and changed its name to Daiwa Securities Group Inc. in 1999. Daiwa Securities Group Inc. was founded in 1902 and is headquartered in Tokyo, Japan.
DiaSorin logo

DiaSorin

OTCMKTS:DSRLF
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.